In Brief: Investigator financial disclosure
This article was originally published in The Gray Sheet
Executive Summary
Investigator financial disclosure: FDA schedules public hearing for July 20 on its proposed regulation on clinical investigator financial disclosure, which was published Sept. 22, 1994 ("The Gray Sheet" Sept. 26, 1994, p. 12). The hearing will take place in the Wilson Auditorium at the National Institutes of Health campus in Bethesda, Maryland. Those interested in participating may give notice by fax at 301/594-0113...
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.